Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Urinary PSA could be an early marker for enlarged prostate.

ChatGPT is preferred for creating dermatology patient handouts, but all models can be useful with oversight.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Hair loss significantly affects quality of life, especially for women, in Pakistan.

Afatinib often causes skin problems that need proactive management.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A 30 Gy radiation dose effectively causes severe radiodermatitis in rabbits.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Men with enlarged prostates often have more severe baldness.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The treatment combination is effective and generally safe for lung cancer.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Drinking sweetened tea and poor sleep habits may increase the risk of hair loss in women.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.